Exabis Library
Welcome to the e-CCO Library!
P0570: Role of dynamic contrast-enhanced ultrasound (D-CEUS) in predicting clinical remission to advanced therapy in ulcerative colitis - a monocenter prospective pilot study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0571: Transmural healingx7x7x7 assessed through the combination of faecal calprotectin and intestinal ultrasoundx7x7x7 is associated with a reduced risk of bowel damage progression in patients with Crohn's disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0572: Impact of objective motility MRI scoring of ileal Crohn’s disease on gastroenterologists treatment assessment: The CONTEXT Trial
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0573: The Burden of Urgency in Ulcerative Colitis: Impact of Disease Duration and Activity
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0574: Correlations Between Inflammatory Biomarkers and Hematological Parameters in Assessing Disease Activity in IBD
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0575: Bronchiectasis in patients with inflammatory bowel disease – prevalencex7x7x7 predictorsx7x7x7 and clinical characteristics
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0576: Ultrasound assessment of sarcopenia and body composition in patients with inflammatory bowel disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0577: Influence of Pregnancy on Outcomes of Inflammatory Bowel Disease and Medication Adherence
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0578: The relationship between the concentration of D-dimer and interleukin-6 in patients with ulcerative colitis.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0579: Predictive Modeling for Colectomy Risk in Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis: A Brazilian Multicentric Study Utilizing Machine Learning.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P057: CRL4DCAF2 promotes cell proliferation and limits the development of colitis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P057: Development and evaluation of the i-Tracker Certolizumab and i-Tracker Anti-Certolizumab kits: rapid and innovative tests intended for monitoring patients treated with Certolizumab.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P057: Gut microbiome diversity in acute severe colitis is distinct from mild-to-moderate ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P057: HLA B27 transgenic rat: a new animal model of postsurgical ileitis in inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P057: IL-6 induces NLRP3 inflammasome activation through JAK/STAT3-dependent NOX2 induction in colon epithelial cells
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P057: Mucosal microbiota adapts to ATF6-induced alterations in host lipid metabolism with prognostic value in colorectal cancer
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P057: Proteomic analysis highlights divergences and convergences between ileal and colonic pathological processes involved in Crohn’s ulcers
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P058 The lived experience of family planning of female patients diagnosed with inflammatory bowel disease and their partners during key reproductive stages: a qualitative study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0580: Efficacy and safety results of tulisokibart re-induction treatment in participants with ulcerative colitis in the Phase 2 ARTEMIS-UC clinical trial
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0582: Do we need a Structured Transition Programme for patients with IBD? The Irish Experience
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM